Literature DB >> 28866646

High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA).

Nadia Bonekamp1, Roberta Caorsi2, Joost Frenkel1, Marco Gattorno2, Gian Maria Viglizzo3, Marlies de Graaf4, Francesca Minoia2, Alice Grossi5, Paolo Picco2, Isabella Ceccherini5.   

Abstract

Entities:  

Keywords:  Fever Syndromes; Inflammation; Treatment

Mesh：

Substances：

Year:  2017        PMID： 28866646     DOI： 10.1136/annrheumdis-2017-211805

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Interleukin-36 Receptor Antagonist Deficiency (DITRA) with a Novel IL36RN Homozygous Mutation c.200G > T (P.Cys67Phe) in a Young Colombian Woman.

Authors:  Andres F Zea-Vera; Felipe E Estupiñan-Lopez; Jaqueline Cifuentes-Burbano; Myriam J Vargas; Anilza Bonelo
Journal:  J Clin Immunol       Date:  2019-04-05       Impact factor: 8.317

Review 2.  Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.

Authors:  Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 3.  The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders.

Authors:  Fiona Moghaddas; Seth L Masters
Journal:  Clin Sci (Lond)       Date:  2018-09-05       Impact factor: 6.124

Review 4.  Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms.

Authors:  Hanna Bonnekoh; Monique Butze; Tilmann Kallinich; Naotomo Kambe; Georgios Kokolakis; Karoline Krause
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.